Account
Articles
09.06.2025
Early Advice, Long-Term Value: How HTA Engagement ...

The key to pricing success for any pharmaceutical product is effectively exhibiting the asset’...

Read more
Insider Insights
09.06.2025
EU Pharma Package Overhaul: Council Agreement Ushe...

Executive Summary  What Has Changed in the Pharma Package?  The Council’s agreed text on the Pha...

Read more
Webinar
28.05.2025
Navigating Early Scientific Advice for Pricing and...

Whether you’re in drug development, market access, or health economics, early scientific advic...

Read more
06.03.2025
How to navigate early payer scientific advice: a B...

Charlie Hewitt from Remap Consulting initiated today’s session by providing a description of the c...

Read more
Publications
15.10.2024
WODC Europe 2024: Comparing And Contrasting Early ...

AUTHORS: Amy Boyers, Solen Monteil, Mariam Bibi OBJECTIVES  Early Access Programmes (EAPs) prov...

Read more
Insider Insights
30.01.2024
New MHRA procedure can accelerate patient access t...

The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has implemented the Interna...

Read more
Articles
13.12.2023
Reflecting on the Pricing & Market Access tre...

Back in January this year, we summarised the key trends our market access experts believed would dom...

Read more
News
16.11.2023
ISPOR Europe 2023

We're thrilled to announce our participation at ISPOR Europe 2023 in Copenhagen this November. We'll...

Read more
Articles
01.11.2023
World Orphan Drug Congress Europe 2023 REPORT

We summarise the World Orphan Drug Congress Europe 2023 including keynote and panel sessions on EU H...

Read more
Articles
08.08.2023
How to get payer scientific advice between now and...

Our market access experts provide an overview of how to get payer scientific advice between Septembe...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.